<img src="https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7?size=2" nborder="0" align="left" hspace="5" vspace="5" title="22157.jpg" alt="Company Logo"/>Increasing dengue infections, expanded disease surveillance, and demand for early diagnosis are expected to support market growth at a CAGR of 4.50% from 2026 to 2033..Dublin, Aug. 31, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- The <a href="https://www.researchandmarkets.com/report/saudi-arabia-dengue-test-market?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=2w5mqh&amp;utm_campaign=2341682+-+Saudi+Arabia+Dengue+Testing+Market+Size%2c+Share+%26+Trends+Analysis+Report+by+Test+Type%2c+Product%2c+End+Use%2c+and+Segment+Forecasts%2c+2026-2033&amp;utm_exec=clshmsai" rel="nofollow" target="_blank" title="Saudi Arabia Dengue Testing Market Size, Share &amp; Trends Analysis Report by Test Type, Product, End Use, and Segment Forecasts, 2026-2033">"Saudi Arabia Dengue Testing Market Size, Share &amp; Trends Analysis Report by Test Type, Product, End Use, and Segment Forecasts, 2026-2033"</a> has been added to ResearchAndMarkets.com's offering. Saudi Arabia Dengue Testing Market to Reach USD 889.83 Thousand by 2033 The Saudi Arabia dengue testing market was valued at USD 624.35 thousand in 2025 and is projected to increase from USD 654.00 thousand in 2026 to USD 889.83 thousand by 2033. The market is forecast to register a compound annual growth rate of 4.50% during the 2026-2033 period, supported by the increasing prevalence of dengue infections and a growing focus on timely, accurate diagnostic testing. Dengue continues to present a public health concern in several areas of Saudi Arabia, particularly in western and southern regions. Jeddah, Makkah, and Jazan remain important locations for dengue prevention, surveillance, and testing initiatives due to environmental conditions that can support mosquito activity and disease transmission. The need to identify infections promptly is strengthening demand for reliable diagnostic products across healthcare and laboratory settings. Expansion of mosquito-borne disease surveillance activities is a key factor influencing the Saudi Arabia dengue testing market. Public health monitoring, testing programs, and greater clinical awareness are contributing to the use of diagnostic methods capable of supporting dengue detection at different stages of infection. Continued attention to outbreak preparedness and disease management is also expected to sustain testing demand through 2033. The market includes established dengue testing methods such as reverse transcription polymerase chain reaction, enzyme-linked immunosorbent assay, NS1 antigen testing, and rapid diagnostic tests. These methods support laboratory confirmation, clinical assessment, surveillance programs, and timely treatment decisions. Demand across individual test categories may vary according to testing capacity, infection stage, turnaround requirements, and the intended healthcare setting. Growing awareness of early dengue diagnosis is also shaping purchasing and testing decisions throughout the country. Earlier identification can support effective clinical management while helping health authorities monitor infection patterns and respond to potential outbreaks. As diagnostic infrastructure and surveillance efforts continue to develop, healthcare providers are expected to place greater emphasis on testing accuracy, accessibility, and operational efficiency. Saudi Arabia Dengue Testing Market Report Segmentation The market report provides revenue forecasts for Saudi Arabia and analyzes current and emerging industry trends across the relevant subsegments from 2021 to 2033. The study evaluates the market based on test type, product, and end use, offering insight into the principal areas influencing demand, adoption, and revenue development. <ul><li>Test Type: Revenue analysis and forecasts in USD thousands from 2021 to 2033.</li><li>Product Outlook: Revenue analysis and forecasts in USD thousands from 2021 to 2033.</li><li>End Use Outlook: Revenue analysis and forecasts in USD thousands from 2021 to 2033.</li></ul> The Saudi Arabia dengue testing market outlook indicates steady growth as healthcare stakeholders strengthen diagnostic readiness and mosquito-borne disease monitoring. Market opportunities are expected to remain closely connected to dengue incidence, testing awareness, surveillance coverage, diagnostic availability, and the adoption of accurate testing methods in regions with elevated infection risk. With market revenue projected to approach USD 890 thousand by 2033, dengue testing will remain an important component of Saudi Arabia's infectious disease response. The report's segmentation and forecast analysis provide a focused assessment of market performance, helping industry participants evaluate growth patterns and understand the factors likely to influence dengue diagnostics demand during the forecast period. Key Topics Covered: Chapter 1. Methodology and Scope 1.1. Market Segmentation and Scope 1.1.1. Segment Definitions 1.1.1.1. Test Type Segment 1.1.1.2. Product Segment 1.1.1.3. End Use Segment 1.2. Estimates and Forecast Timeline 1.2.1. Objectives 1.2.2. Objective - 1 1.2.3. Objective - 2 1.2.4. Objective - 3 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased Database 1.4.2. Internal Database 1.4.3. Secondary Sources 1.4.4. Primary Research 1.5. Information or Data Analysis 1.5.1. Data Analysis Models 1.6. Market Formulation &amp; Validation 1.7. Model Details 1.7.1. Commodity Flow Analysis 1.8. List of Secondary Sources 1.9. List of Abbreviations Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Test Type &amp; Product Snapshot 2.3. End Use Snapshot 2.4. Competitive Landscape Snapshot Chapter 3. Market Variables, Trends, &amp; Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Rising incidence of dengue cases and mosquito-borne diseases 3.2.1.2. Government initiatives and expansion of healthcare infrastructure 3.2.1.3. Growing adoption of advanced diagnostic technologies 3.2.2. Market Restraint Analysis 3.2.2.1. High costs of advanced diagnostic technologies 3.2.2.2. Limited awareness and underdiagnoses in certain countries 3.3. Industry Analysis Tools 3.3.1. Porter's Five Forces Analysis 3.3.2. PESTEL Analysis Chapter 4. Test Type Business Analysis 4.1. Saudi Arabia Dengue Testing Market: Test Type Movement Analysis 4.2. ELISA-Based Tests 4.2.1. ELISA-based Tests Market, 2021 - 2033 (USD Thousands) 4.3. Molecular Diagnostic Kits 4.3.1. Molecular Diagnostic Kits Market, 2021 - 2033 (USD Thousands) 4.4. Rapid Diagnostic Tests (RDTs) 4.4.1. Rapid Diagnostic Tests (RDTs) Market, 2021 - 2033 (USD Thousands) 4.5. Lateral Flow Assays (Antigen-Based) 4.5.1. Lateral Flow Assays (Antigen-based) Market, 2021 - 2033 (USD Thousands) Chapter 5. Product Business Analysis 5.1. Saudi Arabia Dengue Testing Market: Product Movement Analysis 5.2. Consumables 5.2.1. Consumables Market, 2021 - 2033 (USD Thousands) 5.3. Instruments 5.3.1. Instruments Market, 2021 - 2033 (USD Thousands) 5.4. Others 5.4.1. Others Market, 2021 - 2033 (USD Thousands) Chapter 6. End Use Business Analysis 6.1. Hospitals 6.1.1. Hospitals Market, 2021 - 2033 (USD Thousands) 6.2. Diagnostic Laboratories 6.2.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Thousands) 6.3. Government &amp; Public Health Laboratories 6.3.1. Government &amp; Public Health Laboratories Market, 2021 - 2033 (USD Thousands) 6.4. Research Institutes 6.4.1. Research Institutes Market, 2021 - 2033 (USD Thousands) Chapter 7. Competitive Landscape 7.1. Company Categorization 7.2. Strategy Mapping 7.3. Company Market Share Analysis, 2025 7.4. Company Profiles/Listing 7.4.1. Abbott 7.4.1.1. Overview 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.1.3. Technology Benchmarking 7.4.1.4. Strategic Initiatives 7.4.2. F. Hoffmann-La Roche Ltd 7.4.2.1. Overview 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.2.3. Technology Benchmarking 7.4.2.4. Strategic Initiatives 7.4.3. Thermo Fisher Scientific, Inc. 7.4.3.1. Overview 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.3.3. Technology Benchmarking 7.4.3.4. Strategic Initiatives 7.4.4. Bio-Rad Laboratories, Inc. 7.4.4.1. Overview 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.4.3. Technology Benchmarking 7.4.4.4. Strategic Initiatives 7.4.5. SD Biosensor 7.4.5.1. Overview 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.5.3. Technology Benchmarking 7.4.5.4. Strategic Initiatives 7.4.6. QuidelOrtho Corporation 7.4.6.1. Overview 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.6.3. Technology Benchmarking 7.4.6.4. Strategic Initiatives 7.4.7. InBios International, Inc. 7.4.7.1. Overview 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.7.3. Technology Benchmarking 7.4.7.4. Strategic Initiatives 7.4.8. CTK Biotech, Inc. 7.4.8.1. Overview 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.8.3. Technology Benchmarking 7.4.8.4. Strategic Initiatives 7.4.9. GENBODY INC. 7.4.9.1. Overview 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.9.3. Technology Benchmarking 7.4.9.4. Strategic Initiatives List of Tables Table 1 List of abbreviation Table 2 Saudi Arabia dengue testing market, by test type, 2021 - 2033 (USD Thousands) Table 3 Saudi Arabia dengue testing market, by product, 2021 - 2033 (USD Thousands) Table 4 Saudi Arabia dengue testing market, by end use, 2021 - 2033 (USD Thousands) List of Figures Fig. 1 Saudi Arabia dengue testing market segmentation Fig. 2 Market research process Fig. 3 Data triangulation techniques Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value chain based sizing &amp; forecasting Fig. 7 QFD modelling for market share assessment Fig. 8 Market formulation &amp; validation Fig. 9 Market snapshot Fig. 10 Test type and product segment snapshot Fig. 11 End use segment snapshot Fig. 12 Competitive landscape snapshot Fig. 13 In Vitro Diagnostics (IVD) market value, 2025 (USD Billion) Fig. 14 Market trends &amp; outlook Fig. 15 Porter's five force analysis Fig. 16 PESTEL analysis Fig. 17 Saudi Arabia dengue testing market: Test type outlook and key takeaways Fig. 18 Saudi Arabia dengue testing market: Test type movement analysis Fig. 19 ELISA-based tests market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 20 Molecular diagnostic kits market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 21 Rapid diagnostic tests (RDTs) market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 22 Lateral flow assays (antigen-based) market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 23 Saudi Arabia dengue testing market: Product outlook and key takeaways Fig. 24 Saudi Arabia dengue testing market: Product movement analysis Fig. 25 Consumables market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 26 Instruments market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 27 Others market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 28 Saudi Arabia dengue testing market: End use outlook and key takeaways Fig. 29 Saudi Arabia dengue testing market: End use movement analysis Fig. 30 Hospitals market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 31 Diagnostic laboratories market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 32 Government &amp; public health laboratories market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 33 Research institutes market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 34 Key company categorization Fig. 35 Company market share analysis, 2025 Fig. 36 Strategic framework Companies Featured <ul><li>Abbott</li><li>F. Hoffmann-La Roche Ltd</li><li>Thermo Fisher Scientific, Inc.</li><li>Bio-Rad Laboratories, Inc.</li><li>SD Biosensor, Inc.</li><li>QuidelOrtho Corporation</li><li>InBios International, Inc.</li><li>CTK Biotech, Inc.</li><li>GENBODY INC.</li></ul> For more information about this report visit <a href="https://www.researchandmarkets.com/report/saudi-arabia-dengue-test-market?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=2w5mqh&amp;utm_campaign=2341682+-+Saudi+Arabia+Dengue+Testing+Market+Size%2c+Share+%26+Trends+Analysis+Report+by+Test+Type%2c+Product%2c+End+Use%2c+and+Segment+Forecasts%2c+2026-2033&amp;utm_exec=clshmsai" rel="nofollow" target="_blank" title="">https://www.researchandmarkets.com/r/1kkfid</a> About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. <pre>CONTACT: 
CONTACT: ResearchAndMarkets.com 
 Laura Wood,Senior Press Manager 
 press@researchandmarkets.com
 For E.S.T Office Hours Call 1-917-300-0470 
 For U.S./ CAN Toll Free Call 1-800-526-8630 
 For GMT Office Hours Call +353-1-416-8900 

</pre> <img alt="" src='https://ml.globenewswire.com/media/MWY2YTJlYmUtNWU1YS00Y2NmLWExOWEtNjQzMGFjODEyYWE3LTEwMjY3MzctMjAyNi0wOC0zMS1lbg==/tiny/Research-and-Markets.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Saudi Arabia Dengue Testing Market Size, Share & Trends Analysis Report by Test Type, Product, End Use, and Segment Forecasts, 2026-2033

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn